Alemtuzumab in Multiple Sclerosis: Lessons from Social Media in Enhancing Patient Care
Authors: Rath Louise , Vijiaratnam Nirosen , Skibina Olga 
Published: December 2017

CME/CNE InformationActivity Available Online:To access the article, post-test, and evaluation online, go to http://www.cmscscholar.org.Target Audience:The target audience for this activity is physicians, physician assistants, nursing professionals, and other health-care providers involved in the management of patients with multiple sclerosis (MS).Learning Objectives:Accreditation Statement:This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Consortium of Multiple Sclerosis Centers (CMSC), Nurse Practitioner Alternatives (NPA), and Delaware Media Group. The CMSC is accredited by the ACCME to provide continuing medical education for physicians.The CMSC designates this journal-based CME activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.Nurse Practitioner Alternatives (NPA) is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.NPA designates this enduring material for 1.0 Continuing Nursing Education credit (1.0 in the area of pharmacology).Laurie Scudder, DNP, NP, has served as Nurse Planner and reviewer for this activity. She has disclosed no relevant financial relationships.Disclosures:Editor in Chief of the International Journal of MS Care (IJMSC), has served as Physician Planner for this activity. He has received royalties from Springer Publishing, received intellectual property rights/patent holder from Biogen, and has performed contracted research for Biogen.Francois Bethoux, MD,has served as Nurse Planner and reviewer for this activity. She has disclosed no relevant financial relationships.Laurie Scudder, DNP, NP,has received a travel grant from Genzyme.Louise Rath, MA (Bioethics), Grad Dip Crit Care, BA, RN,, has disclosed no relevant financial relationships.Nirosen Vijiaratnam, MBBS, BMedSci, has served on a speakers' bureau for and received a travel grant from Genzyme.Olga Skibina, MD, FRACPThe anonymous peer reviewers for the IJMSC have disclosed no relevant financial relationships.The staff at the IJMSC, CMSC, NPA, and Delaware Media Group who are in a position to influence content have disclosed no relevant financial relationships.Note: Disclosures listed for authors are those applicable at the time of their work on this project and within 12 months previously. Financial relationships for some authors may have changed in the interval between the time of their work on this project and publication of the article and/or the authors may list other older disclosures at the end of the article.Method of Participation:Release Date: December 1, 2017Valid for Credit Through: December 1, 2018In order to receive CME/CNE credit, participants must:Statements of Credit are awarded upon successful completion of the post-test with a passing score of &gt;70% and the evaluation.There is no fee to participate in this activity.Disclosure of Unlabeled Use:This CME/CNE activity may contain discussion of published and/or investigational uses of agents that are not approved by the FDA. CMSC, NPA, and Delaware Media Group do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of CMSC, NPA, or Delaware Media Group.Disclaimer:Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any medications, diagnostic procedures, or treatments discussed in this publication should not be used by clinicians or other health-care professionals without first evaluating their patients' conditions, considering possible contraindications or risks, reviewing any applicable manufacturer's product information, and comparing any therapeutic approach with the recommendations of other authorities.